Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 '22

By: Newsfile

Dallas, Texas--(Newsfile Corp. - April 10, 2023) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): The full report can be accessed by clicking on the following link: https://stonegateinc.com/reports/BPTH_Q422.pdf

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Owning the Breakthrough Technology
  • Ongoing Clinical Trials
  • First Patients Recently Dosed

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7294/161882_figure1_550.jpg

Click image above to view full announcement.


About Stonegate Capital Partners
Stonegate Capital Partners is a Dallas-based corporate advisory firm dedicated to serving the specialized needs of small-cap public companies. Since our inception, our mission has been to find innovative, undervalued public companies for our network of leading institutional investors who seek high-quality investment opportunities.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/161882

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.76
+1.79 (0.79%)
AAPL  268.95
+0.14 (0.05%)
AMD  262.55
+2.88 (1.11%)
BAC  52.47
-0.55 (-1.05%)
GOOG  267.78
-2.15 (-0.80%)
META  752.88
+2.06 (0.27%)
MSFT  543.26
+11.74 (2.21%)
NVDA  194.60
+3.11 (1.63%)
ORCL  284.48
+3.08 (1.09%)
TSLA  464.52
+12.10 (2.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.